During corticosteroid therapy may occur psychological disorders such as: euphoria, insomnia, mood swings, depression or personality disorders and even severe depression or psychosis
Monique Rainford is an OB/GYN expert and Assistant Clinical Professor at Yale School of Medicine
While arGSTs were shown to catalyse the nucleophilic transfer of the tripeptide glutathione (GSH) onto the model substrate 1-chloro-2,4-dinitrobenzene (CDNB) ( 5 ) in vitro, such GSH conjugates with anthocyanins ( 1 ) were never observed in vitro or in planta 19,31,32
Retatrutide's evidence base runs from Phase 2 results published in the New England Journal of Medicine in 2023 (dose-dependent weight reductions near 24%, HbA1c improvements, documented energy-expenditure increases) to Phase 3 TRIUMPH readouts in 20252026, including TRIUMPH-1's ~28% mean reduction at the 12 mg dose
[3] [8] Patients taking oral mesalamine, immunosuppressants, or other time-sensitive medications should discuss optimal timing and monitoring
Others may maintain the weight loss they achieved while on the medication